Immunophenotypic analysis of non-Hodgkin's lymphomas in cytologic specimens: a correlative study of

A Simsir1, P Fetsch, M Stetler-Stevenson

  • 1Laboratory of Pathology, National Institutes of Health/National Cancer Institute, Bethesda, Maryland 20892, USA.

Insights

Immunocytochemistry (IC) and flow cytometry (FC) are effective for diagnosing Non-Hodgkin's lymphoma (NHL) in cytology specimens. Both methods show high correlation, offering complementary strengths for accurate lymphoma classification.

Area of Science:

  • Hematopathology
  • Cytopathology
  • Immunology

Background:

  • Non-Hodgkin's lymphoma (NHL) diagnosis relies on morphology and immunophenotyping of cytology specimens.
  • Immunophenotyping is crucial for classifying NHL and can be performed using immunocytochemistry (IC) or flow cytometry (FC).

Purpose of the Study:

  • To compare the efficacy and correlation of immunocytochemistry (IC) and flow cytometry (FC) for diagnosing Non-Hodgkin's lymphoma (NHL) in cytology specimens.
  • To evaluate the advantages and limitations of IC and FC in the immunophenotypic analysis of NHL.

Main Methods:

  • Retrospective review of 98 cytology specimens (70 fine-needle aspirates, 28 effusions) from January 1992 to December 1997.
  • Immunophenotyping performed using both IC and FC on the collected specimens.
  • Analysis of discrepancies and specimen adequacy for each technique.

Main Results:

  • High correlation (98%) between IC and FC when both techniques were applied to 85% of cases.
  • FC was inadequate for 11% of cases, while IC was inadequate for 4%, highlighting differential specimen requirements.
  • IC preserves cytomorphology, beneficial for necrotic samples; FC excels at detecting small monoclonal populations and offers objective parameters.

Conclusions:

  • Both IC and FC are highly effective and largely interchangeable methods for immunophenotyping cytology specimens in NHL diagnosis.
  • The choice between IC and FC may depend on institutional expertise, available resources, and specific case characteristics, such as specimen cellularity and tumor necrosis.